Table 2.
Quality of Life in Patients With Versus Without Cervical Cancer
All |
Cervical cancer |
Noncancer |
p Value | |
---|---|---|---|---|
(N = 146,336,855) | (N = 275,246) | (N = 146,061,609) | ||
Physical limitations, % | 10.2 | 18.7 | 10.2 | <0.0001 |
Activity limitations, % | 7.5 | 21.1 | 7.5 | <0.0001 |
Social limitations, % | 4.3 | 8.2 | 4.3 | 0.0018 |
Cognitive limitations, % | 3.9 | 9.3 | 3.8 | <0.0001 |
SF-12 PCS, mean (SE) | 49.19 (0.08) | 45.36 (1.17) | 49.20 (0.08) | 0.0011 |
SF-12 MCS, mean (SE) | 50.39 (0.06) | 46.16 (0.99) | 50.40 (0.06) | <0.0001 |
PHQ-2 score, mean (SE) | 0.74 (0.01) | 1.33 (0.14) | 0.74 (0.01) | <0.0001 |
SF-6D utility score, mean (SE) | 0.56 (0.00) | 0.57 (0.01) | 0.56 (0.00) | 0.0157 |
EQ5D utility score, mean (SE) | 0.86 (0.00) | 0.78 (0.01) | 0.86 (0.00) | <0.0001 |
SF-12, 12-Item Short Form Health Survey Version 2; PCS, physical component summary; SE, standard error; MCS, mental component summary; PHQ-2, Patient Health Questionnaire-2; SF-6D; Short-Form Six-Dimension health utility; EQ5D, EuroQol-5D.